Andrew L. Shannon-Little

Statistics

Publications

Citations

256

H-Index

Active since

2019

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Andrew L. Shannon-Little is an author at GlaxoSmithKline (United Kingdom) specializing in catalytic mechanisms, drug toxicity prediction, and redox processes.

ORCID

Publications per year

2019–2023

Publications

Redox-neutral organocatalytic Mitsunobu reactions

Rhydian H. Beddoe, Keith G. Andrews, Valentin Magné et al. · Science · 2019 · 223 citations · Full text

Natural Sciences, Chemistry, Catalysis +9

Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity

David J. Ponting, Michael J. Burns, Robert S. Foster et al. · Methods in molecular biology · 2022 · 23 citations

Pharmacy, Pharmacology, Toxicology +15

Establishing Best Practice for the Application and Support of Solubility Purge Factors

Michael J. Burns, Ian X. Andrews, Jens-Christoph Baumann et al. · Organic Process Research & Development · 2023 · 10 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +15

1–3 of 3